The pharmaceutical industry faces a considerable challenge from the counterfeit drug trade, putting patient safety at risk and jeopardizing the reliability of the worldwide supply chain. As unlawful practices advance, evidenced by a 101% rise in counterfeit drug seizures in 2021 compared to the previous year, pharmaceutical companies urgently require effective solutions to address this growing threat.

Gain expert insights on the evolving landscape of serialization and its implications for the pharmaceutical industry from Patrick Ferguson, Director Customer Success TPU here.